Examine the benefits and challenges of using yeast and vaccines for more effective and consumer-friendly immunization strategies.

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

A new plastic surgery procedure called alloClae allows patients to receive fat transfers from cadavers. The donor-derived tissue "allows surgeons to add volume in a controlled and targeted way without ...

Consolidation of four doses may lower secondary packaging complexity and improve fill-finish throughput predictability, although Lilly has not quantified manufacturing efficiency gains. Multi-dose use ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than ...

Turns out, giant monsters still move the needle. Imagine that? Directed by Adam Wingard, the latest chapter in Legendary ’s MonsterVerse once again unites the King of the Monsters and Skull Island’s ...

Legitimate practitioners say the country has developed some of the worlds leading aesthetic injectors, with highly trained doctors delivering safe, regulated treatments. However, alongside that ...

Conspiracy theories, books and documentaries are largely focused on the idea that someone killed the Nirvana frontman, ...

The Indiana House added several restrictions to the state's syringe exchange programs, but the bill's authors are just grateful for the programs to survive.

A recently published study from Karolinska Institutet shows that mortality among people who inject drugs enrolled in the Stockholm needle and syringe program declined over a 10-year period, with a ...

Syringe exchange has always been a tough political issue in Indiana. This year, lawmakers are proposing further restrictions ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...